BRADY TRUE: Open Payments
NPI 1497485593 · BELOIT, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 13 payments from 8 companies in 2025. Trend: 2023 $132 · 2024 $239 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Amgen Inc. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
Products named: VRAYLAR, EVENITY, JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, CAMZYOS, OTEZLA, LEQVIO.
Industry payments across KS — which companies pay providers there.
